Article 82: Eye On: Diabetes
- CenterWatch combs the R&D pipeline and finds 31 therapies for diabetes in clinical testing.
Article 83: New Buyers for Sites Emerge
- Start-up SMOs are heating up the site-acquisition market.
- CenterWatch looks at seven active SMO buyers and their acquisition strategies.
Article 84: Dedicated Sites Buoyed by Hot Market
-
CenterWatch surveys 36 full-time research sites and shows that most are experiencing a significant increase in demand for their services.
-
In spite of stagnating study budgets, the majority of full-time sites report higher profist due to higher volume of studies.
